| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Bottom |
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Neoplasms Benign, Malignant and Unspecified : Posters : Topoiscmerase Inhibitors : Simultaneous Population Pharmacokinetic (PPK) Modeling of Irinotecan (CPT-11) and its Major Metabolites, SN-38 and SN-38G | published Wed, Nov 7, 2007 - 10:31 EST |
Presented at the 2002 ASCPT Annual Meeting, Atlanta, GA
| Cognigen Corporation - Posters and Presentations : Cognigen Corporation : Clinical : Neoplasms Benign, Malignant and Unspecified : Posters : Topoiscmerase Inhibitors : Simultaneous Population Pharmacokinetic (PPK) Modeling of Irinotecan (CPT-11) and its Major Metabolites, SN-38 and SN-38G | published Wed, Nov 7, 2007 - 10:31 EST |
| Report Top | Up a Page | Previous | Next | Up a Map | TOC | Page Index | File Index | What's New | Page Top |